← FDA Drug Approvals (Drugs@FDA)
ROPIVACAINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2023-10-26
Drug application
- FDA Application #
ANDA206091- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROPIVACAINE HYDROCHLORIDE
- Generic name
- ROPIVACAINE HYDROCHLORIDE
- Active ingredients
- ROPIVACAINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MYLAN LABS LTD
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2023-10-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown